FrancophonIA/ELRC3.0 huggingface dataset:
English: Don't put in any more drops until it's time for the next regular dose.
Slovenian: Kapljic ne vkapajte ponovno, dokler ne bo čas za naslednji redni odmerek.
English: The following adverse reactions are classified according to the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to<1/1,000), very rare <1/10,000), or not known (frequency cannot be estimated from the available data).
Slovenian: Naslednji neželeni učinki so razvrščeni v skladu z naslednjim dogovorom: zelo pogosti (≥1/10), pogosti (≥1/100 do <1/10), občasni (≥1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000), zelo redki (<1/10.000) ali neznana pogostnost (ni je mogoče oceniti iz razpoložljivih podatkov).
English: It may be used on its own or with other drops e.g. beta-blockers, which also reduce pressure.
Slovenian: Uporablja se lahko samostojno ali z drugimi kapljicami, npr. z antagonisti receptorjev beta, ki tudi znižajo tlak.
English: Do not throw away medicine via wastewater or in household waste.
Slovenian: Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
English: What TRAVATAN is and what it is used for
Slovenian: Kaj je zdravilo TRAVATAN in za kaj ga uporabljamo
English: If you or your child receive more TRAVATAN than you should Rinse all the medicine out with warm water.
Slovenian: Če ste vi ali vaš otrok prejeli večji odmerek zdravila TRAVATAN, kot bi smeli Izperite vse zdravilo s toplo vodo.
English: Before treatment is instituted, patients must be informed of the possibility of a permanent change in eye colour.
Slovenian: Pred začetkom zdravljenja morate bolnika opozoriti na možnost trajne spremembe barve oči.
English: Women who are pregnant or attempting to become pregnant should exercise appropriate precautions to avoid direct exposure to the contents of the bottle.
Slovenian: Nosečnice ali ženske, ki skušajo zanositi, morajo uporabljati ustrezne previdnostne ukrepe, da preprečijo neposreden stik z vsebino kapalnega vsebnika.
English: Women of child-bearing potential/contraception
Slovenian: Ženske v rodni dobi/kontracepcija
English: One drop in the affected eye or eyes, once a day - in the evening.
Slovenian: Ena kapljica v prizadeto oko ali obe očesi, enkrat na dan, zvečer.
English: The marketing authorisation holder Novartis Europharm Limited Vista Building
Slovenian: Imetnik dovoljenja za promet z zdravilom Novartis Europharm Limited Vista Building
English: No dosage adjustment is necessary in these patients (see section 5.2).
Slovenian: Prilagoditev odmerka pri teh bolnikih ni potrebna (glejte poglavje 5.2).
English: In a similar 3 month study in adult patients, these events occurred at an incidence of 11.4% and 0.0%, respectively.
Slovenian: V podobni 3-mesečni študiji pri odraslih bolnikih sta se ta dva dogodka pojavila z incidenco 11,4 % oziroma 0,0 %.
English: The effect on IOP was seen after the second week of treatment and was consistently maintained throughout the 12 week period of study for all age groups.
Slovenian: Učinek na očesni tlak je bil opazen po drugem tednu zdravljenja in se je ohranjal skozi celotno 12-tedensko obdobje študije pri vseh starostnih skupinah.
English: The long term effects on the melanocytes and any consequences thereof are currently unknown.
Slovenian: Dolgoročni učinki zdravila na melanocite in njihove morebitne posledice še niso znani.
English: Do not use TRAVATAN if you are pregnant.
Slovenian: Ne uporabljajte zdravila TRAVATAN, če ste noseči.
English: It works by reducing the pressure in the eye.
Slovenian: Deluje tako, da zniža očesni tlak.
English: Other medicines and TRAVATAN Tell your doctor or pharmacist if you are taking or have recently taken or used any other medicines.
Slovenian: Obvestite zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali ali uporabljali katero koli drugo zdravilo.
English: • After using TRAVATAN, keep the eyelid closed, apply gentle pressure by pressing a finger into the corner of the eye, by the nose (picture 4) for at least 1 minute.
Slovenian: • Po uporabi zdravila TRAVATAN držite veko zaprto, nežno pritisnite s prstom na očesni kot ob nosu (slika 4) za vsaj 1 minuto.
English: If you or your child are using other eye preparations such as eye drop or eye ointment, wait for at least 5 minutes between putting in TRAVATAN and the other eye preparations.
Slovenian: Če vi ali vaš otrok uporabljate tudi druga zdravila za oko, kot so kapljice za oko in mazilo za oko, počakajte vsaj 5 minut med uporabo zdravila TRAVATAN in drugih zdravil za oko.
English: Ask your doctor for advice before taking any medicine
Slovenian: Posvetujte se z zdravnikom, preden vzamete katerokoli zdravilo.
English: You can usually carry on using the drops, unless the side effects are serious.
Slovenian: Običajno lahko tudi ob neželenih učinkih nadaljujete z uporabo kapljic, razen če so resni.
English: TRAVATAN may gradually change the eye colour by increasing the number of melanosomes (pigment granules) in melanocytes.
Slovenian: Zdravilo TRAVATAN lahko postopoma spremeni barvo oči, saj poveča število melanosomov (pigmentnih zrnc) v melanocitih.
English: Prostaglandins and prostaglandin analogues are biologically active materials that may be absorbed through the skin.
Slovenian: Prostaglandini in analogi prostaglandinov so biološko aktivne snovi, ki se lahko absorbirajo skozi kožo.
English: In the unlikely event of coming in contact with a substantial portion of the contents of the bottle, thoroughly cleanse the exposed area immediately.
Slovenian: V malo verjetnem primeru stika z večjim delom vsebine kapalnega vsebnika je treba nemudoma temeljito očistiti izpostavljeni predel.
English: If you could become pregnant you must use adequate contraception whilst you use TRAVATAN.
Slovenian: Če bi lahko zanosili, morate uporabljati ustrezno kontracepcijsko zaščito med uporabo zdravila TRAVATAN.
English: While most of the plasma data across all studies was non-quantifiable, making statistical comparisons of systemic exposure across age groups unfeasible, the overall trend shows that plasma exposure to travoprost free acid following topical administration of TRAVATAN is extremely low across all age groups evaluated.
Slovenian: Čeprav večine plazemskih podatkov iz vseh študij ni bilo mogoče kvantificirati, zaradi česar je bila statistična primerjava sistemskih izpostavljenosti med posameznimi starostnimi skupinami neizvedljiva, pa je splošni trend pokazal, da je plazemska izpostavljenost prosti kislini travoprosta po topikalni uporabi zdravila TRAVATAN pri vseh ovrednotenih starostnih skupinah izjemno nizka.
English: It is unknown whether travoprost from the eye drops is excreted in human breast milk.
Slovenian: Ni znano, ali se travoprost iz kapljic za oko izloča v materino mleko.
English: TRAVATAN is used to reduce high pressure in the eye in adults, adolescents and children from 2 months old onward.
Slovenian: Zdravilo TRAVATAN se uporablja za zniževanje zvišanega očesnega tlaka pri odraslih, mladostnikih in otrocih od 2 mesecev starosti naprej.
English: Do not stop taking TRAVATAN without speaking to your doctor.
Slovenian: Ne prenehajte uporabljati zdravila TRAVATAN, ne da bi se pogovorili s svojim zdravnikom.
English: If you are concerned about changes in your breathing pattern when using TRAVATAN advise your doctor as soon as possible.
Slovenian: Če ste zaskrbljeni zaradi sprememb dihanja med uporabo zdravila TRAVATAN, o tem čimprej obvestite svojega zdravnika.
English: Due to the low plasma concentrations and rapid elimination following topical dosing, the elimination half-life of active free acid in man could not be determined.
Slovenian: Zaradi nizke plazemske koncentracije in hitrega izločanja zdravila po topikalnem odmerjanju ni bilo mogoče določiti razpolovne dobe izločanja aktivne proste kisline pri človeku.
English: Only use TRAVATAN for dropping in your or your child's eye(s).
Slovenian: Zdravilo TRAVATAN uporabljajte le za vkapanje v svoje oko(oči) ali v oko(oči) vašega otroka.
English: What you need to know before you use TRAVATAN
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo TRAVATAN
English: • TRAVATAN may rarely cause breathlessness or wheezing or increase the symptoms of asthma.
Slovenian: • Zdravilo TRAVATAN lahko v redkih primerih povzroči težko dihanje ali piskanje v pljučih ali poveča simptome astme.
English: There are no data on the effects of TRAVATAN on human fertility.
Slovenian: Ni podatkov o učinkih zdravila TRAVATAN na plodnost pri človeku.
English: Typically, the brown pigmentation around the pupil spreads concentrically towards the periphery in affected eyes, but the entire iris or parts of it may be become more brownish.
Slovenian: Običajno se rjava barva okoli zenice v prizadetem očesu koncentrično razširi proti periferiji, vendar lahko postane šarenica v celoti ali delno bolj rjava.
English: TRAVATAN can be used in children from 2 months to < 18 years at the same dose as for adults.
Slovenian: Zdravilo TRAVATAN se lahko uporablja pri otrocih od 2 mesecev do < 18 let starosti v istem odmerku kot pri odraslih.
English: Patients must be instructed to remove contact lenses prior to application of TRAVATAN and wait 15 minutes after instillation of the dose before reinsertion.
Slovenian: Bolnikom svetujte, naj kontaktne leče odstranijo pred uporabo zdravila TRAVATAN in po uporabi počakajo še 15 minut, preden si jih spet vstavijo.
English: Changes in the eyelids including unusual hair growth or in the tissues around the eye have also been observed.
Slovenian: Opazili so tudi spremembe v očesnih vekah, ki vključujejo nenavadno rast dlak na vekah ali tkivu okrog očesa.
English: Do not use TRAVATAN after the expiry date which is stated on the bottle and the box after “EXP”.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na kapalnem vsebniku in na škatli poleg oznake „EXP“.
English: Efficacy and safety data in the age group 2 months to < 3 years (9 patients) is limited (see section 5.1).
Slovenian: Podatki o učinkovitosti in varnosti zdravila pri starostni skupini od 2 mesecev do < 3 let (9 bolnikov) so omejeni (glejte poglavje 5.1).
English: If blurred vision occurs at instillation, the patient must wait until the vision clears before driving or using machines.
Slovenian: Če ima po vkapanju kapljic bolnik zamegljen vid, mora počakati, da se mu vid zbistri, preden sme voziti ali upravljati stroje.
English: In children < 3 years old that mainly suffer from PCG (primary congenital glaucoma), surgery (e.g. trabeculotomy/goniotomy) remains the first line treatment.
Slovenian: Pri otrocih starosti < 3 let, ki imajo predvsem PCG (primarni kongenitalni glavkom), je zdravljenje prve izbire še vedno kirurški poseg (npr. trabekulotomija/goniotomija).
English: The systemic metabolic pathways parallel those of endogenous prostaglandin F2 which are characterised by reduction of the 13-14 double bond, oxidation of the 15-hydroxyl and -oxidative cleavages of the upper side chain.
Slovenian: Sistemske presnovne poti so podobne tistim za endogeni prostaglandin F2, za katerega so značilni redukcija dvojne vezi 13-14, oksidacija 15-hidroksila in -oksidativni razcep zgornje stranske verige.
English: • If you have had cataract surgery, talk to your doctor before you use TRAVATAN.
Slovenian: • Če ste imeli operacijo katarakte, se posvetujte s svojim zdravnikom pred uporabo zdravila TRAVATAN.
English: Significant lowering of intraocular pressure can be maintained for periods exceeding 24 hours with a single dose.
Slovenian: Znatno znižanje očesnega tlaka se lahko ohranja dlje kot 24 ur, že po uporabi enega samega odmerka.
English: Within each frequency group, adverse reactions are presented in decreasing order of seriousness.
Slovenian: V razvrstitvah pogostnosti so neželeni učinki navedeni po padajoči resnosti.
English: Specific in vitro interaction studies were performed with TRAVATAN and medicinal products containing thiomersal.
Slovenian: Specifične raziskave medsebojnega delovanja zdravil in vitro so bile opravljene z zdravilom TRAVATAN in zdravili, ki vsebujejo tiomersal.
English: This pressure can lead to an illness called glaucoma.
Slovenian: Ta tlak lahko povzroči bolezen, imenovano glavkom.
English: TRAVATAN should therefore be used with caution in patients with active intraocular inflammation.
Slovenian: Zato morate zdravilo TRAVATAN uporabljati previdno pri bolnikih z akutnim intraokularnim vnetjem.
English: The use of TRAVATAN by breast-feeding mothers is not recommended.
Slovenian: Uporaba zdravila TRAVATAN pri doječih materah ni priporočljiva.
English: TRAVATAN must not be used in women of child bearing age/potential unless adequate contraceptive measures are in place (see section 5.3).
Slovenian: Zdravila TRAVATAN ne smejo uporabljati ženske v rodni dobi, ki bi lahko zanosile, če ne uporabljajo ustrezne kontracepcijske zaščite (glejte poglavje 5.3).
English: The safety and efficacy of TRAVATAN in children below the age of 2 months have not been established.
Slovenian: Varnost in učinkovitosti zdravila TRAVATAN pri otrocih, mlajših od 2 mesecev, še nista bili dokazani.
English: Aqueous humour concentrations declined with a half-life of approximately 1.5 hours.
Slovenian: Koncentracija zdravila v prekatni vodki se je zmanjševala z razpolovno dobo približno 1,5 ur.
English: In a 3 month phase 3 study and a 7 days pharmacokinetic study, involving 102 paediatric patients exposed to TRAVATAN, the types and characteristics of adverse reactions reported were similar to what has been observed in adult patients.
Slovenian: V 3-mesečni študiji 3. faze in 7-dnevni študiji farmakokinetike pri 102 pediatričnih bolnikih, ki so prejemali zdravilo TRAVATAN, so bile vrste in značilnosti zabeleženih neželenih učinkov podobne, kot so jih opažali pri odraslih bolnikih.
English: Reproduction and development studies have demonstrated a potent effect on foetal loss with a high rate observed in rats and mice (180 pg/ml and 30 pg/ml plasma, respectively) at exposures 1.2 to 6 times the clinical exposure (up to 25 pg/ml).
Slovenian: Raziskave reprodukcije in razvoja so pokazale močan učinek zdravila na izgubo plodov-pri podganah in miših so ugotavljali veliko pogostnost (180 pg/ml plazme pri podganah in 30 pg/ml plazme pri miših) pri izpostavljenosti zdravilu, ki je bila 1,2 do 6-krat večja od klinične izpostavljenosti (do 25 pg/ml).
English: If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart (see section 4.5).
Slovenian: Če bolnik sočasno uporablja več topikalnih očesnih zdravil, naj jih uporabi z razmikom najmanj 5 minut (glejte poglavje 4.5).
English: B-2870 Puurs, Belgium.
Slovenian: B-2870, Puurs Belgija ali
English: The mechanism of eyelash changes and their long term consequences are currently unknown.
Slovenian: Mehanizem nastanka teh sprememb trepalnic in njihove dolgoročne posledice še niso znani.
English: Tiny amounts of hydrochloric acid or sodium hydroxide are added to keep acidity levels (pH levels) normal.
Slovenian: Dodane so tudi zelo majhne količine klorovodikove kisline ali natrijevega hidroksida za ohranjanje normalne kislosti (pH vrednosti).
English: In patients with known predisposing risk factors for iritis/uveitis, TRAVATAN should be used with caution.
Slovenian: Pri bolnikih z znanimi predispozicijskimi dejavniki tveganja za nastanek iritisa ali uveitisa morate zdravilo TRAVATAN uporabljati previdno.
English: Pack sizes: 1 or 3 bottles.
Slovenian: Velikosti pakiranj: 1 ali 3 kapalni vsebniki.
English: When substituting another ophthalmic antiglaucoma medicinal product with TRAVATAN, the other medicinal product should be discontinued and TRAVATAN should be started the following day.
Slovenian: Pri prehodu z drugega očesnega zdravila proti glavkomu na zdravilo TRAVATAN naj bolnik preneha jemati prvo zdravilo in začne uporabljati TRAVATAN naslednji dan.
English: Thereafter, plasma levels declined rapidly to below the 10 pg/mL assay quantitation limit before 1 hour post-administration.
Slovenian: Potem je plazemska koncentracija hitro padla pod mejo kvantifikacije 10 pg/ml, še preden je potekla 1 ura po uporabi zdravila.
English: • If you are allergic to travoprost or any of the other ingredients of this medicine (listed in section 6).
Slovenian: Ne uporabljajte zdravila TRAVATAN • če ste alergični na travoprost ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Following topical ocular administration of TRAVATAN to healthy volunteers, low systemic exposure to active free acid was demonstrated.
Slovenian: Po topikalni okularni uporabi zdravila TRAVATAN pri zdravih prostovoljcih so ugotovili majhno sistemsko izpostavljenost aktivni prosti kislini.
English: In the age groups 3 to < 12 years (n=36) and 12 to < 18 years (n=26), mean IOP reduction at Week 12 in the travoprost group was similar to that in the timolol group.
Slovenian: V starostnih skupinah od 3 let do < 12 let (n=36) in od 12 let do < 18 let (n=26) je bila v skupini, ki je prejemala travoprost, srednja vrednost znižanja očesnega tlaka v 12. tednu podobna kot v skupini, ki je prejemala timolol.
English: Data on adjunctive administration of TRAVATAN with timolol 0.5% and limited data with brimonidine 0.2% were collected during clinical trials that showed an additive effect of TRAVATAN with these glaucoma medications.
Slovenian: Podatki o adjuvantni uporabi zdravila TRAVATAN z 0,5 % timololom in omejeni podatki o uporabi z 0,2 % brimonidinom so bili zbrani v kliničnih preskušanjih, ki so pokazala aditivno delovanje zdravila TRAVATAN s temi zdravili proti glavkomu.
English: Use of TRAVATAN is not recommended to those children under 2 months of age.
Slovenian: Uporaba zdravila TRAVATAN ni priporočljiva pri otrocih, mlajših od 2 mesecev.
English: • If you have current or previous history of an eye inflammation (iritis and uveitis), talk to your doctor before you use TRAVATAN.
Slovenian: • Če imate ali ste imeli očesno vnetje (iritis in uveitis), se posvetujte s svojim zdravnikom pred uporabo zdravila TRAVATAN.
English: How to store TRAVATAN Contents of the pack and other information
Slovenian: Shranjevanje zdravila TRAVATAN Vsebina pakiranja in dodatne informacije
English: In children and adolescents, the most common side effects seen with TRAVATAN are eye redness and growth of eyelashes.
Slovenian: Pri otrocih in mladostnikih sta najpogostejša neželena učinka, ki so ju opazili pri zdravilu TRAVATAN, rdečina očesa in rast trepalnic.
English: Mean Difference a
Slovenian: Srednja vrednost razlike a
English: The dose should not exceed one drop in the affected eye(s) daily.
Slovenian: Odmerek ne sme biti večji od ene kapljice v prizadeto oko (oči) na dan.
English: TRAVATAN has been studied in patients with mild to severe hepatic impairment and in patients with mild to severe renal impairment (creatinine clearance as low as 14 ml/min).
Slovenian: TRAVATAN so raziskovali pri bolnikih z blago do hudo jetrno okvaro in pri tistih z blago do hudo ledvično okvaro (očistek kreatinina le 14 ml/min).
English: The efficacy of TRAVATAN in paediatric patients from 2 months to less than 18 years of age was demonstrated in a 12-week, double-masked clinical study of travoprost compared with timolol in 152 patients diagnosed with ocular hypertension or paediatric glaucoma.
Slovenian: Učinkovitost zdravila TRAVATAN pri pediatričnih bolnikih, starih od 2 meseca do manj kot 18 let, so dokazali v 12-tedenski dvojno slepi klinični študiji primerjave travoprosta s timololom pri 152 bolnikih z diagnozo očesne hipertenzije ali pediatričnega glavkoma.
English: The active substance is travoprost 40 micrograms/ml.
Slovenian: Učinkovina je travoprost 40 mikrogramov/ml.
English: Caution is recommended when using Travatan in aphakic patients, pseudophakic patients with a torn posterior lens capsule or anterior chamber lenses, or in patients with known risk factors for cystoid macular oedema.
Slovenian: Priporočamo previdnost pri uporabi zdravila TRAVATAN pri afakičnih bolnikih, psevdofakičnih bolnikih z raztrgano posteriorno lečno kapsulo ali z lečo v sprednjem prekatu ali pri bolnikih z znanimi dejavniki tveganja za cistoidni makularni edem.
English: Each mL of solution contains polyquaternium-1 (POLYQUAD) 10 microgram, propylene glycol 7.5 mg, polyoxyethylene hydrogenated castor oil 40 (HCO-40) 2 mg (see section 4.4.)
Slovenian: En ml raztopine vsebuje polikvaternij-1 (POLYQUAD) 10 mikrogramov, propilenglikol 7,5 mg, makrogolglicerol hidroksistearat 2 mg (glejte poglavje 4.4).
English: In clinical trials with TRAVATAN, the most common adverse reactions were ocular hypearemia and iris hyperpigmentation, occurring in approximately 20% and 6% of patients respectively.
Slovenian: V kliničnih preskušanjih z zdravilom TRAVATAN sta bila najpogostejša neželena učinka očesna hiperemija in hiperpigmentacija šarenice, ki sta se pojavila pri 20 % oziroma 6 % bolnikov.
English: Uncommon hypersensitivity, seasonal allergy
Slovenian: Bolezni imunskega sistema občasni preobčutljivost, sezonske alergije
English: No clinical data are available on adjunctive use with other ocular hypotensive medications.
Slovenian: Kliničnih podatkov o adjuvantni uporabi zdravila TRAVATAN z drugimi očesnimi hipotenzivi ni.
English: TRAVATAN contains travoprost, one of a group of medicines called prostaglandin analogues.
Slovenian: Zdravilo TRAVATAN vsebuje travoprost, ki sodi v skupino zdravil, imenovano prostaglandinski analogi.
English: TRAVATAN getting into the rest of the body
Slovenian: Tako boste preprečili, da bi TRAVATAN prišel v druge dele telesa.
English: In pregnant rat, systemic administration of travoprost at doses more than 200 times the clinical dose during the period of organogenesis resulted in an increased incidence of malformations.
Slovenian: Na brejih podganah je sistemska uporaba travoprosta v odmerkih, večjih od 200-kratnika kliničnega odmerka, v času organogeneze povzročila povečano incidenco malformacij ploda.
English: In ocular toxicity studies in monkeys, administration of travoprost at a dose of 0.45 microgram, twice a day, was shown to induce increased palpebral fissure.
Slovenian: Študije očesne toksičnosti zdravila pri opicah so pokazale, da dajanje travoprosta v odmerku 0,45 mikrogramov dvakrat na dan pogosteje povzroči nastanek palpebralne fisure.
English: A pharmacokinetic study in paediatric patients aged 2 months to < 18 years demonstrated very low plasma exposure to travoprost free acid, with concentrations ranging from below the 10 pg/mL assay limt of quantitation (BLQ) to 54.5 pg/mL.
Slovenian: Študija farmakokinetike pri pediatričnih bolnikih, starih od 2 mesecev do < 18 let, je pokazala zelo nizko plazemsko izpostavljenost prosti kislini travoprosta, pri čemer so se koncentracije gibale od vrednosti pod mejo merljivosti (10 pg/ml) do 54,5 pg/ml.
English: • TRAVATAN may change the colour of your iris (the coloured part of your eye).
Slovenian: • Zdravilo TRAVATAN lahko spremeni barvo šarenice (obarvani del očesa).
English: Each 4 mL bottle will contain 2.5 mL of solution.
Slovenian: Vsak 4 ml kapalni vsebnik vsebuje 2,5 ml raztopine.
English: No data are available for children less than 2 months old.
Slovenian: Podatkov ni na voljo za otroke, mlajše od 2 mesecev.
English: IOP reductions for this group were based on only 6 patients in the timolol group and 9 patients in the travoprost group where 4 patients in the travoprost group versus 0 patients in the timolol group had no relevant mean IOP reduction at Week 12.
Slovenian: Srednja vrednost znižanja očesnega tlaka v tej skupini je bila izračunana za samo 6 bolnikov, ki so prejemali timolol in 9 bolnikov, ki so prejemali travoprost, pri čemer pri 4 bolnikih, ki so prejemali travoprost ter 0 bolnikih, ki so prejemali timolol, ni bilo pomembnejšega znižanja srednje vrednosti očesnega tlaka v 12. tednu.
English: Mean IOP reduction at Week 12 in the 2 months to < 3 years of age group was 1.8 mmHg in the travoprost group and 7.3 mmHg in the timolol group.
Slovenian: V starostni skupini od 2 mesecev do < 3 let je znašala srednja vrednost znižanja očesnega tlaka v 12. tednu 1,8 mmHg v skupini, ki je prejemala travoprost, in 7,3 mmHg v skupini, ki je prejemala timolol.